MyFinsight
Home
Blog
About
Back
Income Statement
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)
source: myfinsight.com
Comprehensive (loss) income
-$62,045K
(-166.48%↓ Y/Y)
Net (loss) income
-$61,618K
(-162.39%↓ Y/Y)
Total other
comprehensive (loss) gain
-$427K
(-313.50%↓ Y/Y)
Interest income
(expense), net
$3,503K
(-7.55%↓ Y/Y)
Other income
$308K
(1000.00%↑ Y/Y)
(loss) income before
income taxes
-$61,618K
(-162.39%↓ Y/Y)
Unrealized (loss) gain on
marketable securities
-$427K
(-313.50%↓ Y/Y)
Total other income
(expense)
$3,811K
(-0.16%↓ Y/Y)
(loss) income from
operations
-$65,429K
(-139.67%↓ Y/Y)
Revenue
$9,325K
(-32.51%↓ Y/Y)
Total operating
expenses
$74,754K
(81.81%↑ Y/Y)
Research and development
$49,501K
(91.46%↑ Y/Y)
Sales, general and
administrative
$25,253K
Back